Title: Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy
Abstract: Movement DisordersVolume 24, Issue 15 p. 2293-2294 Letter to the Editor Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy† Davide Manca MD, Davide Manca MD Neurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalySearch for more papers by this authorGiovanni Cossu MD, Corresponding Author Giovanni Cossu MD [email protected] Neurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalyNeurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalySearch for more papers by this authorDaniela Murgia MD, Daniela Murgia MD Neurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalySearch for more papers by this authorAndrea Molari MD, Andrea Molari MD Neurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalySearch for more papers by this authorPaola Ferrigno MD, Paola Ferrigno MD Neurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalySearch for more papers by this authorEmanuele Marcia MD, Emanuele Marcia MD Neurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalySearch for more papers by this authorMaurizio Melis MD, Maurizio Melis MD Neurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalySearch for more papers by this author Davide Manca MD, Davide Manca MD Neurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalySearch for more papers by this authorGiovanni Cossu MD, Corresponding Author Giovanni Cossu MD [email protected] Neurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalyNeurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalySearch for more papers by this authorDaniela Murgia MD, Daniela Murgia MD Neurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalySearch for more papers by this authorAndrea Molari MD, Andrea Molari MD Neurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalySearch for more papers by this authorPaola Ferrigno MD, Paola Ferrigno MD Neurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalySearch for more papers by this authorEmanuele Marcia MD, Emanuele Marcia MD Neurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalySearch for more papers by this authorMaurizio Melis MD, Maurizio Melis MD Neurology Service, AOB, "S. Michele" General Hospital, Cagliari, ItalySearch for more papers by this author First published: 30 September 2009 https://doi.org/10.1002/mds.22807Citations: 58 † Potential conflict of interest: None reported. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Postuma RB,Lang AE. Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy? Neurology 2004; 63: 886–891. 2 Toth C,Sutton Brown M,Furtado S, et al. Neuropathy as a potential complication of levodopa use in Parkinson's disease. Mov Disord 2008; 23: 1850–185. 3 Yoshida K,Moriwaka F,Matsuura T, et al. Myoclonus and seizures in a patient with parkinsonism: induction by levodopa and its confirmation on SEPs. Jpn J Psychiatr Neurol 1993; 47: 621–625. 4 Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol 2006; 5: 949–960. 5 Green R. Current concepts in the diagnosis of cobalamine deficiency. Neurology 1995; 45: 1435–1440. 6 Filippo TS,Holder WD. Neurologic degeneration associated with nitrous oxide anaesthesia in patients with vitamin B12 deficiency. Arch Surg 1993; 128: 1391–1395. 7 Antonini A,Isaias IU,Canesi M, et al. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome. Mov Disord 2007; 22: 1145–1149. Citing Literature Volume24, Issue1515 November 2009Pages 2293-2294 ReferencesRelatedInformation
Publication Year: 2009
Publication Date: 2009-09-30
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 68
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot